Literature DB >> 2375990

Astrocytes cultured from specific brain regions differ in their expression of adrenergic binding sites.

P Ernsberger1, L Iacovitti, D J Reis.   

Abstract

We sought to characterize regional heterogeneity of astrocytes using adrenergic receptor sites as cellular markers. Primary cultures made from 6 regions of neonatal rat brain consisted almost exclusively of astrocytes. Membranes from astrocytes cultured 1-3 weeks were prepared for radioligand binding assays of beta- and alpha 2-adrenergic sites using the ligands [3H]dihydroalprenolol and [3H]p-aminoclonidine, respectively. Receptor expression was not affected by time in culture. Astrocytes from different brain regions varied up to 3-fold with respect to number but not affinity for both classes of adrenergic binding site with a rank order of cerebral cortex = superior colliculus greater than hippocampus = ventral midbrain greater than or equal to caudate nucleus greater than or equal to hypothalamus. Binding to beta- and alpha 2-adrenergic receptors was positively correlated across brain regions. Astrocytic receptor binding in each region did not correspond to total receptor levels assessed by quantitative autoradiography. We conclude that: (a) astrocytes are markedly heterogeneous between major brain regions with respect to expression of adrenergic binding sites; (b) regional variations in the density of adrenergic binding sites in brain reflect, in part, local specialization of astrocytes; and (c) a substantial proportion of the adrenergic binding sites in some brain regions may be on astrocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375990     DOI: 10.1016/0006-8993(90)91027-e

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Iterative optimal design of PET experiments for estimating beta-adrenergic receptor concentration.

Authors:  R F Muzic; G M Saidel; N Zhu; A D Nelson; L Zheng; M S Berridge
Journal:  Med Biol Eng Comput       Date:  2000-11       Impact factor: 2.602

Review 2.  The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.

Authors:  P Ernsberger; J E Friedman; R J Koletsky
Journal:  J Hypertens Suppl       Date:  1997-01

3.  Localized proton MR spectroscopy of the allocortex and isocortex in healthy children.

Authors:  C G Choi; T S Ko; H K Lee; J H Lee; D C Suh
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

4.  Role of β-adrenoceptors in glucose uptake in astrocytes using β-adrenoceptor knockout mice.

Authors:  Stephanie L Catus; Marie E Gibbs; Masaaki Sato; Roger J Summers; Dana S Hutchinson
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

5.  Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS.

Authors:  Jason G Emsley; Jeffrey D Macklis
Journal:  Neuron Glia Biol       Date:  2006-08

6.  A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Authors:  P Ernsberger; M A Haxhiu; L M Graff; L A Collins; I Dreshaj; D L Grove; M E Graves; S G Schäfer; M O Christen
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

7.  Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.

Authors:  Tu-Hsueh Yeh; Da Yong Lee; Scott M Gianino; David H Gutmann
Journal:  Glia       Date:  2009-08-15       Impact factor: 7.452

8.  A comparative antibody analysis of pannexin1 expression in four rat brain regions reveals varying subcellular localizations.

Authors:  Angela C Cone; Cinzia Ambrosi; Eliana Scemes; Maryann E Martone; Gina E Sosinsky
Journal:  Front Pharmacol       Date:  2013-02-06       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.